176 related articles for article (PubMed ID: 6259722)
21. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of advanced carcinoma of the prostate with Estracyt (author's transl)].
Nagel R; Kölln CP
Med Klin; 1976 Oct; 71(41):1724-8. PubMed ID: 824540
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma. A preliminary report from a randomized multicenter study.
Lundgren R; Sundin T; Colleen S; Lindstedt E; Wadström L; Carlsson S; Hellsten S; Pompeius R; Holmquist B; Nilsson T
Scand J Urol Nephrol; 1986; 20(2):101-5. PubMed ID: 3529368
[TBL] [Abstract][Full Text] [Related]
24. Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate.
Catane R; Mittelman A; Kaufman J; Murphy GP
N Y State J Med; 1976 Nov; 76(12):1978-81. PubMed ID: 1069190
[No Abstract] [Full Text] [Related]
25. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
Vahlensieck W; Wegner G
Scand J Urol Nephrol Suppl; 1980; 55():147-9. PubMed ID: 6938018
[TBL] [Abstract][Full Text] [Related]
26. Primary treatment of prostatic carcinoma with estramustine phosphate: preliminary report.
Nilsson T; Jonsson G
J Urol; 1976 Feb; 115(2):168-9. PubMed ID: 1249870
[TBL] [Abstract][Full Text] [Related]
27. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
Kalland T; Haukaas S
Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
[TBL] [Abstract][Full Text] [Related]
28. Extended therapy of stage D carcinoma of the prostate with oral estramustine phosphate.
Mittelman A; Shukla SK; Murphy GP
J Urol; 1976 Apr; 115(4):409-12. PubMed ID: 1263317
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
[No Abstract] [Full Text] [Related]
30. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
Stridsklev IC; Fosså SD; Kaalhus O
Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
[No Abstract] [Full Text] [Related]
31. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
Catane R; Kaufman J; Mittelman A; Murphy GP
J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
[TBL] [Abstract][Full Text] [Related]
32. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
Benson RC; Gill GM; Cummings KB
Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
[No Abstract] [Full Text] [Related]
33. Estramustine phosphate: a specific chemotherapeutic agent?
Von Hoff DD; Rozencweig M; Slavik M; Muggia FM
J Urol; 1977 Apr; 117(4):464-6. PubMed ID: 850319
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostate.
Johansson JE; Andersson SO; Beckman KW; Lingårdh G; Zador G
Urology; 1987 Jan; 29(1):55-9. PubMed ID: 3798631
[TBL] [Abstract][Full Text] [Related]
35. [Estracyt treatment in prostatic neoplasms].
Sander S
Tidsskr Nor Laegeforen; 1976 Jan; 96(1):27-8. PubMed ID: 1257949
[No Abstract] [Full Text] [Related]
36. Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy.
Catane R; Kaufman J; Mittelman A; Murphy GP
JAMA; 1977 Jun; 237(23):2471. PubMed ID: 576957
[No Abstract] [Full Text] [Related]
37. Clinical experimental randomized study of 2.6-cis-diphenylhexamethylcyclotetrasiloxane and estramustine-17-phosphate in the treatment of prostatic carcinoma.
Edsmyr F; Esposti PL; Johansson B; Strindberg B
J Urol; 1978 Dec; 120(6):705-7. PubMed ID: 731810
[TBL] [Abstract][Full Text] [Related]
38. Treatment of stage D hormone-resistant carcinoma of the prostate with estramustine phosphate.
Benson RC; Wear JB; Gill GM
J Urol; 1979 Apr; 121(4):452-4. PubMed ID: 439216
[TBL] [Abstract][Full Text] [Related]
39. Comparison of flutamide and Emcyt in hormone-refractory metastatic prostatic cancer.
de Kernion JN; Murphy GP; Priore R
Urology; 1988 Apr; 31(4):312-7. PubMed ID: 3281365
[TBL] [Abstract][Full Text] [Related]
40. Estracyt--clinical experiences.
Nilsson T
Scand J Urol Nephrol Suppl; 1980; 55():135-8. PubMed ID: 6938016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
